Dermatologicals in Lithuania
DERMATOLOGICALS IN LITHUANIA
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Parental Care Drives Sales of Products for Babies
Hair Products Lose Dynamism
Parasites Vanish
Competitive Landscape
Dermatologicals Dominated by International Players
Presence of New Entrants and Private Label Still Limited
Canesten Gains in Vaginal Antifungals
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023
Executive Summary
Market Is Moving Towards Smart Consumption
Healthy Economy Leads To Healthy Dynamic and Competition
Mixed Trio at the Top
Major Channel Expected To Lose Share
Saturation and Shrinking Consumer Base Against Growing Income
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 8 Life Expectancy at Birth 2013-2018
Market Data
Table 9 Sales of Consumer Health by Category: Value 2013-2018
Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 13 Penetration of Private Label by Category: % Value 2013-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Summary 1 OTC: Switches
Sources
Summary 2 Research Sources
With the majority of categories within dermatologicals being quite well established and therefore saturated in Lithuania, the products targeting baby care are demonstrating strong growth in 2018. With the purchasing power and education of Lithuanians rising, sales of nappy (diaper) rash treatments lead growth of the whole category. In addition, market players are paying extra attention to the new opportunities to grow their business, thus trying to constantly offer new improved products. At the...
Euromonitor International's Dermatologicals in Lithuania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.